CASTLE was a @-week study comparing efficacy and safety in treatment-naive HIV-@-infected patients randomized to atazanavir/ritonavir ( ATV/r ) versus lopinavir/ritonavir ( LPV/r ) , each in combination with tenofovir disoproxil fumarate/emtricitabine .